Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
As the holding company of the Medipak Systems Business Area, Körber Medipak Systems GmbH is aiming to use the acquisition to extend its expertise in the cutting-edge market for software solutions in the field of production control and monitoring. ...
read more
Tuesday, December 20, 2022
Kite, a Gilead Company and Tmunity Therapeutics (Tmunity), announced that the companies have signed an agreement in which Kite will acquire Tmunity, a clinical-stage, private biotech company focused on next-generation CAR T-therapies and technologies...
read more
With the global market for asthma and COPD drugs set to reach $47bn in 2017, inhalation drug delivery systems are gathering momentum as pharmaceutical companies develop faster acting and more effective orally inhaled products. It is crucial for ...
read more
Thursday, October 08, 2020
KemPharm has expanded its relationship with Corium through a new consultation services agreement under which KemPharm will provide product development consultation services to Corium.
read more
Monday, September 12, 2022
KCAS Bioanalytical and Biomarker Services (KCAS), a bioanalytical contract research organization (CRO), backed by Vitruvian Partners, closed the purchase of Active Biomarkers, located in Lyon, France.
read more
Tuesday, December 03, 2024
KBI Biopharma, Inc. announced a manufacturing contract with Alanis Therapeutics, Inc. (ATI) for the development of an innovative pre-clinical therapeutic antibody to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) blood cancers...
read more
Monday, December 03, 2018
KBI Biopharma and Selexis have appointed four leading, internationally recognized scientists to their newly formed Joint Scientific Advisory Board (JSAB).
read more
KBI Biopharma Inc., a JSR Life Sciences company, and AM-Pharma, an emerging leader focused on the development of therapeutics that protect organ function in patients with severe medical conditions, have signed a commercial manufacturing agreement to ...
read more
Tuesday, November 29, 2022
Kaneka Corporation will manufacture and supply intermediates to Shionogi & Co., Ltd. for use in Xocova® (Ensitrelvir Fumaric Acid) Tablets 125mg, a drug for the treatment of SARS-Cov-2 infection.
read more
Tuesday, September 12, 2017
Kaneka Eurogentec announced its board has approved the construction of a new state of-the-art GMP facility adjacent to its current facility and equipped with a 2200 L fermenter.
read more
Thursday, September 22, 2022
Kaléo announced the execution of the first contract with the U.S. Department of Defense (DoD) for the procurement of the Rapid Opioid Countermeasure System (ROCS), a 10 mg Naloxone Auto-injector (naloxone hydrochloride injection) antidote for ultra-...
read more
Juniper Pharmaceuticals has entered into a definitive agreement with Catalent to acquire all of the outstanding shares of Juniper at a price of $11.50 per share in cash.
read more
Thursday, August 15, 2013
Jubilant HollisterStier announced today that the Montreal-based manufacturing facility has completed the first phase of an expansion of their sterile manufacturing capacity, with the addition of a new ampoule filling line utilizing a rigid barrier ...
read more
Wednesday, March 17, 2021
Jubilant Life Sciences has signed new contract with Eli Lilly for contract manufacturing of a treatment for COVID-19.
read more
Jubilant Pharmova Limited has announced that Jubilant Pharma Limited, a wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, Jubilant HollisterStier LLC, (JHS) a leading US-based pharmaceutical contract manufacturer ...
read more